vs
西蒙地产集团（ELS）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是西蒙地产集团的1.2倍（$493.8M vs $397.6M），西蒙地产集团同比增速更快（6.3% vs -1.7%），过去两年西蒙地产集团的营收复合增速更高（2.3% vs -0.1%）
西蒙地产集团是美国头部房地产投资信托企业，投资范围涵盖购物中心、奥特莱斯及社区生活中心等商业地产业态，是美国规模最大的购物中心持有方，总部位于印第安纳州印第安纳波利斯，截至2024年12月末共持有232处物业权益。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
ELS vs MD — 直观对比
营收规模更大
MD
是对方的1.2倍
$397.6M
营收增速更快
ELS
高出8.0%
-1.7%
两年增速更快
ELS
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $397.6M | $493.8M |
| 净利润 | — | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | — | 9.9% |
| 净利率 | — | 6.8% |
| 营收同比 | 6.3% | -1.7% |
| 净利润同比 | — | 10.5% |
| 每股收益（稀释后） | $0.56 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELSMD
| Q1 26 | $397.6M | — | ||
| Q4 25 | $373.9M | $493.8M | ||
| Q3 25 | $393.3M | $492.9M | ||
| Q2 25 | $376.9M | $468.8M | ||
| Q1 25 | $387.3M | $458.4M | ||
| Q4 24 | $372.3M | $502.4M | ||
| Q3 24 | $387.3M | $511.2M | ||
| Q2 24 | $380.0M | $504.3M |
净利润ELSMD
| Q1 26 | — | — | ||
| Q4 25 | $103.8M | $33.7M | ||
| Q3 25 | $100.4M | $71.7M | ||
| Q2 25 | $83.5M | $39.3M | ||
| Q1 25 | $114.4M | $20.7M | ||
| Q4 24 | $100.6M | $30.5M | ||
| Q3 24 | $86.9M | $19.4M | ||
| Q2 24 | $82.1M | $-153.0M |
营业利润率ELSMD
| Q1 26 | — | — | ||
| Q4 25 | 26.5% | 9.9% | ||
| Q3 25 | 25.1% | 13.8% | ||
| Q2 25 | 22.3% | 12.8% | ||
| Q1 25 | 28.3% | 7.0% | ||
| Q4 24 | 27.2% | 7.8% | ||
| Q3 24 | 21.4% | 6.6% | ||
| Q2 24 | 21.5% | -31.3% |
净利率ELSMD
| Q1 26 | — | — | ||
| Q4 25 | 27.8% | 6.8% | ||
| Q3 25 | 25.5% | 14.5% | ||
| Q2 25 | 22.2% | 8.4% | ||
| Q1 25 | 29.5% | 4.5% | ||
| Q4 24 | 27.0% | 6.1% | ||
| Q3 24 | 22.4% | 3.8% | ||
| Q2 24 | 21.6% | -30.3% |
每股收益（稀释后）ELSMD
| Q1 26 | $0.56 | — | ||
| Q4 25 | $0.52 | $0.40 | ||
| Q3 25 | $0.50 | $0.84 | ||
| Q2 25 | $0.42 | $0.46 | ||
| Q1 25 | $0.57 | $0.24 | ||
| Q4 24 | $0.51 | $0.37 | ||
| Q3 24 | $0.44 | $0.23 | ||
| Q2 24 | $0.42 | $-1.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $375.2M |
| 总债务越低越好 | — | $570.5M |
| 股东权益账面价值 | $1.8B | $865.9M |
| 总资产 | $5.7M | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资ELSMD
| Q1 26 | — | — | ||
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M |
总债务ELSMD
| Q1 26 | — | — | ||
| Q4 25 | $3.3B | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | $3.2B | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ELSMD
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $865.9M | ||
| Q3 25 | $1.8B | $890.7M | ||
| Q2 25 | $1.7B | $833.8M | ||
| Q1 25 | $1.7B | $789.2M | ||
| Q4 24 | $1.7B | $764.9M | ||
| Q3 24 | $1.4B | $732.5M | ||
| Q2 24 | $1.4B | $706.5M |
总资产ELSMD
| Q1 26 | $5.7M | — | ||
| Q4 25 | $5.7B | $2.2B | ||
| Q3 25 | $5.7B | $2.2B | ||
| Q2 25 | $5.7B | $2.1B | ||
| Q1 25 | $5.6B | $2.0B | ||
| Q4 24 | $5.6B | $2.2B | ||
| Q3 24 | $5.6B | $2.1B | ||
| Q2 24 | $5.6B | $2.0B |
负债/权益比ELSMD
| Q1 26 | — | — | ||
| Q4 25 | 1.91× | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 1.84× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ELSMD
| Q1 26 | — | — | ||
| Q4 25 | $571.1M | $114.1M | ||
| Q3 25 | $147.0M | $137.3M | ||
| Q2 25 | $131.3M | $137.2M | ||
| Q1 25 | $193.4M | $-117.5M | ||
| Q4 24 | $596.7M | $133.0M | ||
| Q3 24 | $149.5M | $91.8M | ||
| Q2 24 | $143.1M | $107.0M |
自由现金流ELSMD
| Q1 26 | — | — | ||
| Q4 25 | $334.1M | — | ||
| Q3 25 | $75.7M | — | ||
| Q2 25 | $71.8M | — | ||
| Q1 25 | $148.2M | — | ||
| Q4 24 | $355.4M | — | ||
| Q3 24 | $91.1M | — | ||
| Q2 24 | $80.6M | — |
自由现金流率ELSMD
| Q1 26 | — | — | ||
| Q4 25 | 89.4% | — | ||
| Q3 25 | 19.3% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 38.3% | — | ||
| Q4 24 | 95.5% | — | ||
| Q3 24 | 23.5% | — | ||
| Q2 24 | 21.2% | — |
资本支出强度ELSMD
| Q1 26 | — | — | ||
| Q4 25 | 63.4% | — | ||
| Q3 25 | 18.1% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 11.7% | — | ||
| Q4 24 | 64.8% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 16.5% | — |
现金转化率ELSMD
| Q1 26 | — | — | ||
| Q4 25 | 5.50× | 3.39× | ||
| Q3 25 | 1.46× | 1.91× | ||
| Q2 25 | 1.57× | 3.49× | ||
| Q1 25 | 1.69× | -5.66× | ||
| Q4 24 | 5.93× | 4.36× | ||
| Q3 24 | 1.72× | 4.72× | ||
| Q2 24 | 1.74× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELS
| Rental income | $339.0M | 85% |
| Other | $37.2M | 9% |
| Annual membership subscriptions | $18.3M | 5% |
| Membership upgrade revenue | $3.1M | 1% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
